Skip to main content
Top

Drugs

Issue 6/2013

Content (9 Articles)

Cryptococcal Infections: Changing Epidemiology and Implications for Therapy

  • Current Opinion

Ricardo M. La Hoz, Peter G. Pappas

Cytochrome P450-Mediated Changes in Oxycodone Pharmacokinetics/Pharmacodynamics and Their Clinical Implications

  • Review Article

Karin C. Söderberg Löfdal, Marine L. Andersson, Lars L. Gustafsson

Identification and Assessment of Adherence-Enhancing Interventions in Studies Assessing Medication Adherence Through Electronically Compiled Drug Dosing Histories: A Systematic Literature Review and Meta-Analysis

  • Open Access
  • Systematic Review

Jenny Demonceau, Todd Ruppar, Paulus Kristanto, Dyfrig A. Hughes, Emily Fargher, Przemyslaw Kardas, Sabina De Geest, Fabienne Dobbels, Pawel Lewek, John Urquhart, Bernard Vrijens

Pomalidomide: First Global Approval

  • R&D Insight Report

Shelley Elkinson, Paul L. McCormack

Ospemifene: First Global Approval

  • R&D Insight Report

Shelley Elkinson, Lily P. H. Yang

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images